COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

April 27, 2020 00:22:04
Episode Cover

Vasopressors & The Older Patient - The 65 Trial

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic...

Listen

Episode 0

February 14, 2017 00:29:35
Episode Cover

Surviving Sepsis Campaign 2016 Update

The SSC recently published its new recommendations for the management of sepsis and septic shock.  We discuss the key changes and controversies that you...

Listen

Episode 0

July 07, 2023 00:28:56
Episode Cover

VL versus DL...And The Winner Is?

Over 1 million critically ill patients undergo intubation each year in the United States.  Though direct laryngoscopy remains the most common technique worldwide for...

Listen